Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

When targeting problem proteins involved in causing or spreading disease, a drug will often clog up a protein’s active site so it can’t function and wreak havoc.

How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’

In the last two years, telehealth has gone all in on GLP-1s. Dozens of companies have started to offer the wildly popular obesity and diabetes

October 17, 2024

Straumann Group acquires AlliedStar, an intraoral scanner provider in China – Biotech Investments

Straumann Holding AG / Key word(s): Acquisition/Miscellaneous 21-Sep-2023 / 19:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

September 22, 2023

Frontier Medicines raises $80M, enters clinic and eyes potential IPO in Q4 or early 2025

Frontier Medicines, a bicoastal biotech creating covalent small molecules, has secured $80 million in Series C funds and dosed the first patient in its initial

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.